Noori Goodarzi N, Barzi S, Ajdary S, Chiani M, Yekaninejad M, Badmasti F
J Transl Med. 2025; 23(1):261.
PMID: 40038701
PMC: 11877727.
DOI: 10.1186/s12967-025-06256-1.
Harris-Jones T, Perez Medina K, Hackett K, Schave M, Klimowicz A, Schaub R
J Bacteriol. 2023; 205(12):e0027723.
PMID: 38038461
PMC: 10729727.
DOI: 10.1128/jb.00277-23.
Harris-Jones T, Perez Medina K, Hackett K, Schave M, Schaub R, Dillard J
bioRxiv. 2023; .
PMID: 37662418
PMC: 10473753.
DOI: 10.1101/2023.08.23.554517.
Banks E, Lambert C, Mason S, Tyson J, Radford P, McLaughlin C
J Bacteriol. 2023; 205(4):e0047522.
PMID: 37010281
PMC: 10127604.
DOI: 10.1128/jb.00475-22.
Yahashiri A, Kaus G, Popham D, Houtman J, Weiss D
J Bacteriol. 2022; 204(9):e0025222.
PMID: 36005810
PMC: 9487507.
DOI: 10.1128/jb.00252-22.
XAC4296 Is a Multifunctional and Exclusive Gene Containing a Fusion of Lytic Transglycosylase and Epimerase Domains.
de Oliveira A, Ferreira R, Ferro M, Ferro J, Zamuner C, Ferreira H
Microorganisms. 2022; 10(5).
PMID: 35630451
PMC: 9143381.
DOI: 10.3390/microorganisms10051008.
The AmiC/NlpD Pathway Dominates Peptidoglycan Breakdown in Neisseria meningitidis and Affects Cell Separation, NOD1 Agonist Production, and Infection.
Chan J, Hackett K, Woodhams K, Schaub R, Dillard J
Infect Immun. 2022; 90(3):e0048521.
PMID: 35225652
PMC: 8929373.
DOI: 10.1128/IAI.00485-21.
Understanding tolerance to cell wall-active antibiotics.
Dorr T
Ann N Y Acad Sci. 2020; 1496(1):35-58.
PMID: 33274447
PMC: 8359209.
DOI: 10.1111/nyas.14541.
Defective lytic transglycosylase disrupts cell morphogenesis by hindering cell wall de--acetylation in .
Williams A, Wheeler R, Deghmane A, Santecchia I, Schaub R, Hicham S
Elife. 2020; 9.
PMID: 32022687
PMC: 7083599.
DOI: 10.7554/eLife.51247.
Structural basis of denuded glycan recognition by SPOR domains in bacterial cell division.
Alcorlo M, Dik D, De Benedetti S, Mahasenan K, Lee M, Dominguez-Gil T
Nat Commun. 2019; 10(1):5567.
PMID: 31804467
PMC: 6895207.
DOI: 10.1038/s41467-019-13354-4.
The lytic transglycosylase, LtgG, controls cell morphology and virulence in Burkholderia pseudomallei.
Jenkins C, Wallis R, Allcock N, Barnes K, Richards M, Auty J
Sci Rep. 2019; 9(1):11060.
PMID: 31363151
PMC: 6667503.
DOI: 10.1038/s41598-019-47483-z.
Lytic transglycosylases RlpA and MltC assist in Vibrio cholerae daughter cell separation.
Weaver A, Jimenez-Ruiz V, Tallavajhala S, Ransegnola B, Wong K, Dorr T
Mol Microbiol. 2019; 112(4):1100-1115.
PMID: 31286580
PMC: 6800776.
DOI: 10.1111/mmi.14349.
A Mutant, Lacking the Soluble Lytic Transglycosylase Slt, Exhibits Defects in Both Growth and Virulence.
Bachert B, Biryukov S, Chua J, Rodriguez S, Toothman Jr R, Cote C
Front Microbiol. 2019; 10:1343.
PMID: 31258523
PMC: 6587636.
DOI: 10.3389/fmicb.2019.01343.
The Pathogenic Neisseria Use a Streamlined Set of Peptidoglycan Degradation Proteins for Peptidoglycan Remodeling, Recycling, and Toxic Fragment Release.
Schaub R, Dillard J
Front Microbiol. 2019; 10:73.
PMID: 30766523
PMC: 6365954.
DOI: 10.3389/fmicb.2019.00073.
PBP3 and PBP4 Facilitate NOD1 Agonist Peptidoglycan Fragment Release and Survival in Stationary Phase.
Schaub R, Perez-Medina K, Hackett K, Garcia D, Dillard J
Infect Immun. 2018; 87(2).
PMID: 30510100
PMC: 6346134.
DOI: 10.1128/IAI.00833-18.
Antibiotic Targets in Gonococcal Cell Wall Metabolism.
Perez Medina K, Dillard J
Antibiotics (Basel). 2018; 7(3).
PMID: 30037076
PMC: 6164560.
DOI: 10.3390/antibiotics7030064.
Structural studies and molecular dynamics simulations suggest a processive mechanism of exolytic lytic transglycosylase from Campylobacter jejuni.
Vijayaraghavan J, Kumar V, Krishnan N, Kaufhold R, Zeng X, Lin J
PLoS One. 2018; 13(5):e0197136.
PMID: 29758058
PMC: 5951611.
DOI: 10.1371/journal.pone.0197136.
Attention Seeker: Production, Modification, and Release of Inflammatory Peptidoglycan Fragments in Neisseria Species.
Chan J, Dillard J
J Bacteriol. 2017; 199(20).
PMID: 28674065
PMC: 5637178.
DOI: 10.1128/JB.00354-17.
Lytic transglycosylases: concinnity in concision of the bacterial cell wall.
Dik D, Marous D, Fisher J, Mobashery S
Crit Rev Biochem Mol Biol. 2017; 52(5):503-542.
PMID: 28644060
PMC: 6102726.
DOI: 10.1080/10409238.2017.1337705.
Bulgecin A: The Key to a Broad-Spectrum Inhibitor That Targets Lytic Transglycosylases.
Williams A, Wheeler R, Thiriau C, Haouz A, Taha M, Boneca I
Antibiotics (Basel). 2017; 6(1).
PMID: 28241458
PMC: 5372988.
DOI: 10.3390/antibiotics6010008.